3-CHLORO-2-METHYLPROPAN-1-AMINE HCL, 95.0%, 500mg

Plan phase S40x/0.65 infinity corrected objective

6-Bromo-benzo[1,3]dioxole-5-carbaldehyde, 98.0%, 1g

1-(5-BROMO-4-METHYLPYRIDIN-2-YL)HYDRAZINE, 95.0%, 5g

2-(2,4-DIFLUOROPHENYL)-1-(PYRIDIN-3-YL)ETHAN-1-ONE, 95.0%, 100mg

4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one, 98%, 1g

6-METHOXY-5-METHYL-3-PYRIDINECARBOXALDEHYDE, 95.0%, 100mg

1-(4-Aminophenyl)-4-(N,N-dimethylamino)-piperidine, 95.0%, 1g

4-Propoxybenzaldehyde>97.0%(GC)25mL

3-Acetoxy-4'-ethylbenzophenone, 90.0%, 1g

2-Amino-5-bromo-2'-fluorobenzophenone, 95.0%, 25g

1-Bromo-2,3,5-trifluorobenzene>98.0%(GC)1g

2-Methylnaphth[2,1-d]oxazole>98.0%(GC)5g